Are you Dr. Jensen?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 55 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1500 Duarte Rd
Mob 4th Floor
Duarte, CA 91010Phone+1 626-301-8993
Summary
- Dr. Michael Jensen, MD is a pediatric hematologist/oncologist in Duarte, California.
Education & Training
University of WashingtonFellowship, Pediatric Hematology/Oncology, 1993 - 1996
Children's Hospital-OaklandResidency, Pediatrics, 1990 - 1993
Perelman School of Medicine at the University of PennsylvaniaClass of 1990
Publications & Presentations
PubMed
- Bioconjugation of Synthetic Peptides onto Universal Chimeric Antigen Receptor T Cells for Targeted Cancer Immunotherapies.Ian I Cardle, Dylan R Scherer, Michael C Jensen, Suzie H Pun, Drew L Sellers
ACS Nano. 2025-02-11 - DNA Aptamer-Polymer Conjugates for Selective Targeting of Integrin α4β1T-Lineage Cancers.Ian I Cardle, Jai Raman, Dinh Chuong Nguyen, Tong Wang, Abe Y Wu
ACS Applied Materials & Interfaces. 2025-01-22 - Differential protein-protein interactions underlie signaling mediated by the TCR and a 4-1BB domain-containing CAR.Samuel A Ritmeester-Loy, Isabella H Draper, Eric C Bueter, Jonathan D Lautz, Yue Zhang-Wong
Science Signaling. 2024-03-05
Press Mentions
City of Hope Researchers Achieve Remission Using CAR-T Cell Therapy for Aggressive Brain TumorsDecember 28th, 2016
Grant Support
- Targeted Therapy Of All With Gene-Modified Central Memory T CellsNational Cancer Institute2009–2011
- Clinical Trial: Pilot/Feasibility Study To Evaluate The Safety Of CellularNational Center For Research Resources2008
- Cellular Immunotherapy For Follicular Lymphoma Using CD19- Specific T-CellsNational Cancer Institute2007–2008
- Pilot/Feasibility Study To Evaluate The Safety Of CellularNational Center For Research Resources2007
- Cellular Immunotherapy Of Glioblastoma Multiforme Using AnNational Center For Research Resources2007
- Pilot Feasibility And Safety Study Of Cellular Immunotherapy For Recurrent/RefNational Center For Research Resources2005–2007
- Glioma Immunotherapy Usingengineered T-CellsNational Cancer Institute2005–2006
- CD19 Specific Immunotherapy For Follicular LymphomaNational Cancer Institute2004–2006
- Pilot Feasibility And Safety Study Of Cell ImmunotherapyNational Center For Research Resources2004
- Glioma Immunotherapy Using Engineered T-CellsNational Cancer Institute2004
- Cellular Immunotherapy For Neuroblastoma With CTL ClonesNational Cancer Institute2001–2002
- Targeting Malignant B Cells In Lymphoma And LeukemiaNational Cancer Institute2000–2002
- Core--Metabolic Human Studies--ObesityNational Institute Of Diabetes And Digestive And Kidney Diseases1996
